- Home
- IMVT vs ONDS Comparison
IMVT vs ONDS Comparison
Compare IMVT & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMVT | ONDS |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.8B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IMVT | ONDS |
|---|---|---|
| Price | $24.02 | $8.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $30.78 | $19.83 |
| AVG Volume (30 Days) | 997.2K | ★ 82.8M |
| Earning Date | 02-06-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.68 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,192,694.00 |
| Revenue This Year | N/A | $256.57 |
| Revenue Next Year | N/A | $77.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.72 | $0.66 |
| 52 Week High | $29.25 | $15.28 |
Technical Indicators
Market Signals| Indicator | IMVT | ONDS |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 38.76 |
| Support Level | $22.00 | $6.20 |
| Resistance Level | $24.63 | $11.87 |
| Average True Range (ATR) | 1.16 | 0.89 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 32.41 | 2.00 |
Price Performance
Historical ComparisonAbout IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.